U.S. flag

An official website of the United States government

NM_018139.3(DNAAF2):c.186G>C (p.Glu62Asp) AND not specified

Germline classification:
Benign (3 submissions)
Last evaluated:
Jul 22, 2015
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000081941.26

Allele description [Variation Report for NM_018139.3(DNAAF2):c.186G>C (p.Glu62Asp)]

NM_018139.3(DNAAF2):c.186G>C (p.Glu62Asp)

Gene:
DNAAF2:dynein axonemal assembly factor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q21.3
Genomic location:
Preferred name:
NM_018139.3(DNAAF2):c.186G>C (p.Glu62Asp)
HGVS:
  • NC_000014.9:g.49634964C>G
  • NG_013070.1:g.5267G>C
  • NM_001083908.2:c.186G>C
  • NM_018139.3:c.186G>CMANE SELECT
  • NP_001077377.1:p.Glu62Asp
  • NP_060609.2:p.Glu62Asp
  • NP_060609.2:p.Glu62Asp
  • NC_000014.8:g.50101682C>G
  • NM_018139.2:c.186G>C
  • Q9NVR5:p.Glu62Asp
Protein change:
E62D
Links:
UniProtKB: Q9NVR5#VAR_057788; dbSNP: rs2985684
NCBI 1000 Genomes Browser:
rs2985684
Molecular consequence:
  • NM_001083908.2:c.186G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_018139.3:c.186G>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
74

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000113876Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Benign
(Jul 22, 2015)
germlineclinical testing

Citation Link,

SCV000205176Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Benign
(Feb 21, 2013)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000313195PreventionGenetics, part of Exact Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benigngermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided7774not providednot providednot providedclinical testing
not providedgermlineunknown2not providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Eurofins Ntd Llc (ga), SCV000113876.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided2not providednot providednot provided

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000205176.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided77not providednot providedclinical testing PubMed (1)

Description

Glu62Asp in exon 1 of DNAAF2: This variant is not expected to have clinical sign ificance because it has been identified in 42.6% (1571/3688) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs2985684).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided77not provided74not provided

From PreventionGenetics, part of Exact Sciences, SCV000313195.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024